Evidence of incomplete proinsulin processing has previously been detected in patients with type 2 diabetes (T2DM) [10–12], as well as people with rare polymorphisms in prohormone convertases [13, 14]. This evidence concerns the gene INS and type 2 diabetes mellitus.